We are live on
!
Find out more
AIM
Aigen Investment Management Portfolio holdings
AUM
$389M
1-Year Est. Return
16.77%
This Fund
S&P 500
This Quarter
Est. Return
-28.09%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$753M
AUM Growth
+$149M
(+25%)
Cap. Flow
+$464M
Cap. Flow
% of AUM
61.59%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,737
New
568
Increased
434
Reduced
241
Closed
491
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$11.5M |
| 2 |
Nucor
NUE
|
+$9.58M |
| 3 |
Microsoft
MSFT
|
+$9.57M |
| 4 |
Duke Energy
DUK
|
+$9.38M |
| 5 |
Costco
COST
|
+$7.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$10M |
| 2 |
FirstEnergy
FE
|
+$7.33M |
| 3 |
Exelon
EXC
|
+$6.32M |
| 4 |
Cincinnati Financial
CINF
|
+$6.04M |
| 5 |
Johnson Controls International
JCI
|
+$5.79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.54% |
| 2 | Healthcare | 14.02% |
| 3 | Financials | 13.64% |
| 4 | Consumer Discretionary | 11.63% |
| 5 | Industrials | 11.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
BOK Financial
BOKF
$8.7B
| $805K | 0.11% |
+18,924
| New | +$1.33M |
|
277
John B. Sanfilippo & Son
JBSS
$965M
| $804K | 0.11% |
8,993
+5,300
| +144% | +$427K |
|
278
CarGurus
CARG
$3.35B
| $802K | 0.11% |
42,347
+28,872
| +214% | +$827K |
|
|
RETA
279
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $802K | 0.11% |
5,555
+858
| +18% | +$166K |
|
280
Chevron
CVX
$382B
| $799K | 0.11% |
+11,023
| New | +$1.09M |
|
|
APLS
281
DELISTED
Apellis Pharmaceuticals
APLS
| $788K | 0.1% |
+29,412
| New | +$1.04M |
|
282
Agios Pharmaceuticals
AGIO
$1.95B
| $785K | 0.1% |
22,114
+13,636
| +161% | +$630K |
|
|
CLDR
283
DELISTED
Cloudera, Inc.
CLDR
| $785K | 0.1% |
99,686
+63,647
| +177% | +$621K |
|
284
American Eagle Outfitters
AEO
$3.07B
| $782K | 0.1% |
98,352
+66,154
| +205% | +$841K |
|
|
SC
285
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $779K | 0.1% |
56,000
+17,929
| +47% | +$399K |
|
286
Simply Good Foods
SMPL
$956M
| $776K | 0.1% |
40,296
+21,388
| +113% | +$468K |
|
287
Golub Capital BDC
GBDC
$3.41B
| $774K | 0.1% |
+62,891
| New | +$1.03M |
|
|
NXRT
288
NexPoint Residential Trust
NXRT
$641M
| $770K | 0.1% |
30,559
+9,267
| +44% | +$406K |
|
289
MarketAxess Holdings
MKTX
$5.72B
| $766K | 0.1% |
2,302
+2,175
| +1,713% | +$758K |
|
290
Cirrus Logic
CRUS
$6.11B
| $763K | 0.1% |
+11,626
| New | +$859K |
|
|
DAY
291
DELISTED
Dayforce
DAY
| $762K | 0.1% |
+15,218
| New | +$1.01M |
|
292
CDW
CDW
$17.1B
| $758K | 0.1% |
+8,127
| New | +$995K |
|
|
MYOK
293
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $758K | 0.1% |
16,171
+14,819
| +1,096% | +$950K |
|
|
XLRN
294
DELISTED
Acceleron Pharma
XLRN
| $757K | 0.1% |
8,428
+4,490
| +114% | +$349K |
|
295
Ball Corp
BALL
$16.6B
| $749K | 0.1% |
11,577
-77,380
| -87% | -$5.42M |
|
|
CMA
296
DELISTED
Comerica
CMA
| $744K | 0.1% |
+25,354
| New | +$1.38M |
|
297
Under Armour Class C
UA
$2.42B
| $743K | 0.1% |
+92,139
| New | +$1.32M |
|
298
MaxLinear
MXL
$6.21B
| $739K | 0.1% |
+63,347
| New | +$1.06M |
|
299
Roper Technologies
ROP
$39.9B
| $739K | 0.1% |
2,370
+2,222
| +1,501% | +$787K |
|
300
LyondellBasell Industries
LYB
$20.2B
| $732K | 0.1% |
14,744
+14,737
| +210,529% | +$1.08M |
|
Similar funds
SA
WCM
PFPGI
PG
SI
TCM
HBWM
DAM
Aigen Investment Management's Q1 2020 Portfolio in Review
As of Q1 2020, Aigen Investment Management held 1,737 positions worth $753M, up 25% from $604M the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Aigen Investment Management deployed $464M of net new capital in Q1 2020, opening 568 new positions and adding to 434 existing holdings. Its largest new stake was Nucor: 215,804 shares worth $7.77M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Zoetis, an estimated $10M trimmed.
- Aigen Investment Management's largest Q1 2020 buy was Nucor: 215,804 shares worth $7.77M.
- Aigen Investment Management added most to Thermo Fisher Scientific in Q1 2020, an estimated $11.5M increase.
- Aigen Investment Management's biggest Q1 2020 reduction was Zoetis, cutting an estimated $10M.
- Aigen Investment Management fully exited FirstEnergy in Q1 2020, selling an estimated $7.33M.
- Aigen Investment Management's ten largest holdings make up 9.4% of its $753M portfolio in Q1 2020.
- Aigen Investment Management opened 568 new positions and closed 491 in Q1 2020.
- Aigen Investment Management's portfolio value rose 25% quarter-over-quarter to $753M.
Based on Aigen Investment Management's 13F filing for Q1 2020, filed 8 May 2020.